Forbes’ Ranking Of America’s Richest Self-Made Women 2026
It was a banner year for the country’s most successful women with a record number of billionaires, soaring fortunes thanks to AI and an all-time high in total wealth....
Ambrosia Biosciences Announces Preclinical Data Supporting Differentiated Profile of AMB-702, its Novel Small Molecule GLP-1 Receptor Agonist Development Candidate
OrsoBio to Present Preclinical and Clinical Data from its Mitochondrial Protonophore Portfolio at the American Diabetes Association’s 2026 Scientific Sessions
Command the Clone Wars’™ Most Cunning Operatives in Star Wars Zero Company™, Launching August 27
FINAL FANTASY VII REVELATION Announced — Experience the Journey’s End in Spring 2027
Ractigen Therapeutics Announces ADA 2026 Late-Breaking Presentation Highlighting saRNA as a New Frontier in Obesity Control
Ambrosia Biosciences Announces Preclinical Data Supporting Differentiated Profile of AMB-702, its Novel Small Molecule GLP-1 Receptor Agonist Development Candidate
If you find yourself telling an AI things you'd never say to your partner, your therapist, or your best friend, you're not broken — you're just exhausted from performing
A hundred years ago, a man built the "Isolator" helmet because he couldn't focus. Imagine what he'd build today.
The most underrated piece of self-development advice is to stop trying to be understood by everyone — and the people who learn it early get back hours of their week they had been spending in conversations that were never going to produce the understanding
There's a particular kind of clarity that arrives in your 50s and 60s — not from therapy, not from books, not from any deliberate practice — just from having lived long enough to notice which of your beliefs about yourself were inherited, which were chose
Hanoi turns to underground technology to revive rivers
Americans Respond to Financial Pressures With Smarter Spending and Increased Saving, New KeyBank Pulse Poll Finds
Bellevue University: Forbes Recognizes Online Finance Program
Dubai Banks Are Now Using Blockchain in Real Finance—Here’s What Changed
Other News
BBC Türkçe
31.05
World Cup 2026: Uruguay squad incluces Man Utd midfielder Manuel Ugarte but no Luis Suarez
Reuters Global
31.05
Stablecoin demand may soon fade, BoE's Greene says
Morning Star
31.05
United Imaging Spotlights Molecular Imaging Showstoppers at SNMMI 2026
Morning Star
31.05
Kulani Kinis Makes Miami Swim Week Debut with "Endless" Runway Experience and SOJOS Eyewear Collaboration
BBC Türkçe
31.05
KSI quits YouTube collective Sidemen after 13 years
AP Press
31.05
Ukraine boosts its defenses near Belarus amid concerns the Russian ally will join the war
BBC Türkçe
31.05
Man Utd kid Tyler Fletcher's remarkable Scotland World Cup call
Morning Star
31.05
CPKC to maintain rail operations across Canada during IBEW strike
Morning Star
31.05
Here's how Gap's yoga-wear maker Athleta went from must-have to 'generic'
Morning Star
31.05
'I have no preexisting conditions': I'm 56, earn $198,000 and want to retire early. Can I afford private healthcare?
AP Press
31.05
Daraxonrasib vs. pancreatic cancer: Experimental pill helped people live longer
Morning Star
31.05
Ivonescimab with Chemotherapy Demonstrated a Statistically Significant Overall Survival Benefit Compared to Tislelizumab Plus Chemotherapy in 1L Treatment of Patients with Squamous NSCLC in the HARMONi-6 Study Conducted by Akeso in China
Morning Star
31.05
HARMONi-6 Demonstrates Significant Overall Survival Benefit (HR=0.66): Ivonescimab Plus Chemotherapy Superior to PD-1 Plus Chemotherapy in First-Line sq-NSCLC Landmark Results to Be Presented at ASCO 2026 Plenary Session
AP Press
31.05
Game 7: Spurs at Thunder to decide Western Conference crown
BBC Türkçe
31.05
Women's FA Cup final LIVE: Brighton & Hove Albion vs Manchester City - score, radio commentary, text updates & match stats
Morning Star
31.05
Tempus Unveils the Next-Generation of Lens, Expanding its Agentic AI Platform for Oncology Drug Development
Morning Star
31.05
RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) pivotal data show strong and durable responses in advanced head and neck cancer where options remain limited
Morning Star
31.05
Johnson & Johnson's Phase 3 prostate cancer study shows ERLEADA® (apalutamide) before and after surgery significantly reduces risk of metastasis or death, breaking a decades-long treatment paradigm
AP Press
31.05
Festival honoring Lithuania’s iconic cold beet soup brings thousands to Vilnius
Morning Star
31.05
Lilly's Retevmo (selpercatinib) demonstrated an 83% reduction in the risk of disease recurrence or death as adjuvant therapy for people with early-stage RET fusion-positive lung cancer
Morning Star
31.05
Kelonia Therapeutics Presents Updated First-in-Human Data from Phase 1 inMMyCAR Study of KLN-1010 in vivo BCMA CAR-T Therapy at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
Morning Star
31.05
Pfizer’s BRAFTOVI Regimen Nearly Doubles Median Progression-Free Survival in Metastatic Colorectal Cancer
AP Press
31.05
Israeli army captures strategic castle in Lebanon in deepest incursion into country in 26 years
AP Press
31.05
Family is donating Claude Lemieux's brain to Boston University's CTE Center